Research ArticleLiver disease

Targeting diacylglycerol acyltransferase 2 for the treatment of nonalcoholic steatohepatitis

See allHide authors and affiliations

Science Translational Medicine  27 Nov 2019:
Vol. 11, Issue 520, eaav9701
DOI: 10.1126/scitranslmed.aav9701

Article Information

vol. 11 no. 520

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication November 6, 2018
  • Resubmitted February 25, 2019
  • Accepted for publication November 8, 2019
  • .

Author Information

  1. Neeta B. Amin1,*,
  2. Santos Carvajal-Gonzalez2,
  3. Julie Purkal1,
  4. Tong Zhu2,
  5. Collin Crowley1,
  6. Sylvie Perez1,
  7. Kristin Chidsey2,
  8. Albert M. Kim1 and
  9. Bryan Goodwin1
  1. 1Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge, MA 02139, USA.
  2. 2Early Clinical Development, Pfizer Worldwide Research and Development, Cambridge, MA 02139, USA.
  1. *Corresponding author. Email: neeta.amin{at}pfizer.com

Altmetric

Article usage

Article usage: November 2019 to June 2021

AbstractFullPdf
Nov 20192509344216
Dec 20193698598461
Jan 202017199285
Feb 202016566031
Mar 20207818045
Apr 20201744543
May 20201473828
Jun 20201515431
Jul 20201364239
Aug 20201062715
Sep 20201725737
Oct 20201714936
Nov 20201207047
Dec 20201022278
Jan 2021920287
Feb 2021718583
Mar 20211520297
Apr 202123287118
May 202119414111
Jun 2021412233

Stay Connected to Science Translational Medicine

Navigate This Article